Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Pharmacodynamic“
Suchtreffer
Begriffe & Kennungen
Carvykti · 4.5 · No pharmacokinetic or pharmacodynamic drug interaction studies have been performed with CARVYKTI.
Eintrag öffnenCellCept · 4.5 · 50 Oral contraceptives The pharmacodynamics and pharmacokinetics of oral contraceptives were not affected to a
Eintrag öffnenCellCept · 4.5 · Oral contraceptives The pharmacodynamics and pharmacokinetics of oral contraceptives were not affected to a cl
Eintrag öffnenCellCept · 4.5 · Oral contraceptives The pharmacodynamics and pharmacokinetics of oral contraceptives were not affected to a cl
Eintrag öffnenCellCept · 4.5 · Oral contraceptives The pharmacodynamics and pharmacokinetics of oral contraceptives were not affected to a cl
Eintrag öffnenCinacalcet Accordpharma · 4.5 · Warfarin: Multiple oral doses of cinacalcet did not affect the pharmacokinetics or pharmacodynamics (as measur
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · Multiple oral doses of cinacalcet did not affect the pharmacokinetics or pharmacodynamics (as measured by prot
Eintrag öffnenCircadin · 4.5 · 3 Pharmacodynamic interactions
Eintrag öffnenClopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel HCS · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel Krka · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel TAD · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · 6 pharmacodynamic interaction between clopidogrel and acetylsalicylic acid is possible, leading to increased r
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · 7 Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction i
Eintrag öffnenClopidogrel ratiopharm · 4.5 · 6 pharmacodynamic interaction between clopidogrel and acetylsalicylic acid is possible, leading to increased r
Eintrag öffnenClopidogrel ratiopharm · 4.5 · 7 Inconsistent data on the clinical implications of this pharmacokinetic (PK)/pharmacodynamic (PD) interaction
Eintrag öffnen